RBMS2 and prostate carcinoma: An interaction of NEAT1 with steroid receptor coactivator‐3 (SCR‐3), which is essentially needed for prostate cancer cell proliferation and growth (Zhou et al., 2005) via promoting insulin‐like growth factor receptor 1 (IGFR1) transcription followed by AKT signaling activation in prostate cancer, was observed by Xiong et al.